USOR - Virginia Cancer Specialists - Gainesville Office — Gainesville, Virginia

USOR - Virginia Cancer Specialists - Gainesville Office is a clinical research site located in Gainesville, Virginia, United States 20155.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

USOR - Virginia Cancer Specialists - Gainesville Office has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Large B-cell Lymphoma, Myelofibrosis.

Sponsors: ADC Therapeutics S.A., Karyopharm Therapeutics Inc.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Gainesville

Browse all research sites in Virginia · View every site in Gainesville

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for USOR - Virginia Cancer Specialists - Gainesville Office?

USOR - Virginia Cancer Specialists - Gainesville Office has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has USOR - Virginia Cancer Specialists - Gainesville Office conducted?

USOR - Virginia Cancer Specialists - Gainesville Office has 2 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-cell Lymphoma, Myelofibrosis.

Is USOR - Virginia Cancer Specialists - Gainesville Office accredited by Crixeo Clinical Trials?

USOR - Virginia Cancer Specialists - Gainesville Office has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about USOR - Virginia Cancer Specialists - Gainesville Office?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.